Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypoallergenic formula prescribing practices in Australia.

Andrew Kemp1

  • 1Department of Allergy, Immunology and Infectious Diseases, The Children's Hospital, Westmead, Australia. andrewk5@chw.edu.au

Journal of Paediatrics and Child Health
|April 25, 2006
PubMed
Summary

Hypoallergenic formula prescribing shows significant regional variation in Australia, with amino acid formula (AAF) use rising notably. These prescribing patterns may not align with current allergy treatment guidelines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Empowering people with acquired brain injury to master their well-being: a thematic analysis of participant experience of an 8-week positive psychotherapy group.

International journal of qualitative studies on health and well-being·2025
Same author

Medical and surgical interventions for neurotrophic keratopathy.

The Cochrane database of systematic reviews·2025
Same author

Editorial: Insights in emotion science.

Frontiers in psychology·2025
Same author

Technology-enabled CONTACT tracing in care homes in the COVID-19 pandemic: the CONTACT non-randomised mixed-methods feasibility study.

Health technology assessment (Winchester, England)·2025
Same author

Collective behavior diverges independently of the benthic-limnetic axis in stickleback.

Behavioral ecology and sociobiology·2025
Same author

CONTACT: a non-randomised feasibility study of bluetooth-enabled wearables for contact tracing in UK care homes during the COVID-19 pandemic.

Pilot and feasibility studies·2024

Area of Science:

  • Pediatric Nutrition
  • Allergy Management
  • Health Services Research

Background:

  • Hypoallergenic formulas are crucial for managing cow's milk allergy and preventing allergic diseases in infants.
  • Understanding prescribing patterns of specialized infant formulas is essential for effective healthcare resource allocation and guideline adherence.

Purpose of the Study:

  • To analyze the prescribing trends of hypoallergenic formulas, specifically amino acid formula (AAF) and extensively hydrolyzed formula (eHF), across Australian states and territories.
  • To investigate potential correlations between formula prescribing rates and the availability of pediatric specialists.

Main Methods:

  • Utilized prescription supply data from the Australian Health Insurance Commission for 2003-2004.
  • Calculated prescription rates per 1000 children aged 4 years and under for each state.

Related Experiment Videos

  • Correlated formula prescribing data with the number of pediatricians and pediatric allergists per state.

    • Main Results:

    • A significant increase in amino acid formula (AAF) prescriptions was observed starting in 2001.
    • Marked regional disparities in AAF prescribing were identified, with some states having 6-7 times higher rates than others.
    • Prescribing rates of extensively hydrolyzed formula (eHF) were consistently lower than AAF across all regions.
    • No clear relationship was found between AAF prescribing rates and the density of pediatricians or allergists.

    Conclusions:

    • Significant geographical variations in hypoallergenic formula prescribing exist in Australia, unrelated to allergic disease prevalence.
    • Amino acid formula (AAF) may be frequently used as a first-line treatment for cow's milk allergy and for allergy prevention, contrary to established guidelines.
    • There is a need to review Pharmaceutical Benefits Scheme guidelines and assess healthcare providers' knowledge and perceptions regarding appropriate hypoallergenic formula use.